Valneva Newsletter / Valneva Impfstoff Aktie Wird Plotzlich Zum Borsen Hit Focus Online - valneva issued part a of the phase 1/2 clinical trial data for its vaccine in a press release quoting england's health secretary matt hancock as saying the jab produced "a strong immune response".
Admin
– September 14, 2021